AU2001236009A1 - P-glycoprotein modifier-containing medicinal compositions to be delivered to thelarge intestine - Google Patents
P-glycoprotein modifier-containing medicinal compositions to be delivered to thelarge intestineInfo
- Publication number
- AU2001236009A1 AU2001236009A1 AU2001236009A AU3600901A AU2001236009A1 AU 2001236009 A1 AU2001236009 A1 AU 2001236009A1 AU 2001236009 A AU2001236009 A AU 2001236009A AU 3600901 A AU3600901 A AU 3600901A AU 2001236009 A1 AU2001236009 A1 AU 2001236009A1
- Authority
- AU
- Australia
- Prior art keywords
- thelarge
- glycoprotein
- intestine
- modifier
- delivered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000-57630 | 2000-03-02 | ||
JP2000057630 | 2000-03-02 | ||
PCT/JP2001/001546 WO2001064253A1 (fr) | 2000-03-02 | 2001-03-01 | Compositions medicinales renfermant un agent modificateur de la glycoproteine p pour administration au gros intestin |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001236009A1 true AU2001236009A1 (en) | 2001-09-12 |
Family
ID=18578379
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001236009A Abandoned AU2001236009A1 (en) | 2000-03-02 | 2001-03-01 | P-glycoprotein modifier-containing medicinal compositions to be delivered to thelarge intestine |
Country Status (4)
Country | Link |
---|---|
US (1) | US20030158097A1 (fr) |
EP (1) | EP1260233A1 (fr) |
AU (1) | AU2001236009A1 (fr) |
WO (1) | WO2001064253A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8163797B2 (en) * | 2003-12-31 | 2012-04-24 | Actavis Elizabeth Llc | Method of treating with stable pravastatin formulation |
AU2008230364A1 (en) * | 2007-03-26 | 2008-10-02 | Teikoku Seiyaku Co., Ltd. | Oral pharmaceutical preparation for colon-specific delivery |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5756527A (en) * | 1995-06-07 | 1998-05-26 | Ontogen Corporation | Imidazole derivatives useful as modulators of multi drug resistances |
US6245805B1 (en) * | 1995-10-26 | 2001-06-12 | Baker Norton Pharmaceuticals, Inc. | Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents |
JPH09268165A (ja) * | 1996-01-31 | 1997-10-14 | Nisshin Flour Milling Co Ltd | アミノエチルエーテル誘導体 |
JPH11217338A (ja) * | 1997-11-26 | 1999-08-10 | Mitsui Chem Inc | キノリン誘導体を用いる医薬品の効果改善および増強剤 |
-
2001
- 2001-03-01 AU AU2001236009A patent/AU2001236009A1/en not_active Abandoned
- 2001-03-01 US US10/220,551 patent/US20030158097A1/en not_active Abandoned
- 2001-03-01 EP EP01908178A patent/EP1260233A1/fr not_active Withdrawn
- 2001-03-01 WO PCT/JP2001/001546 patent/WO2001064253A1/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1260233A1 (fr) | 2002-11-27 |
WO2001064253A1 (fr) | 2001-09-07 |
US20030158097A1 (en) | 2003-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU781269C (en) | Pharmaceutical compositions | |
HUP0203451A3 (en) | Pharmaceutical compositions of anti-tubercular drugs and process for their preparation | |
IL156531A0 (en) | Lipid nanoparticles, their preparation and pharmaceutical compositions containing them | |
HUP0105021A3 (en) | Compositions having improved delivery of actives and process for their preparation | |
AU2002222118A1 (en) | Pharmaceutical compositions for inhalation | |
IL195237A0 (en) | Conjugates of aziridinyl-epothilone analogs and pharmaceutical compositions comprising same | |
AU2001250420A1 (en) | Pharmaceutical compositions | |
AU2002239397A1 (en) | Drug formulation having improved oral tolerability | |
AU2001274307A1 (en) | Pharmaceutical compositions | |
AU6219601A (en) | Pharmaceutical compositions | |
HUP0002512A3 (en) | Medicinal compositions for application to mucosa | |
PL373850A1 (en) | Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same | |
HUP0302130A3 (en) | Combination pharmaceutical compositions and process for their preparation | |
IL151314A0 (en) | Micelles, methods for their preparation and methods for delivery of micelles to patients | |
AU2002214324A1 (en) | Medicinal compositions | |
AU8576801A (en) | Pharmaceutical compositions | |
AU2001290239A1 (en) | Medicinal composition | |
AU1390002A (en) | Pharmaceutical compositions | |
HUP0300626A3 (en) | Use of progestogen and mifepristone for preparation of anticancer pharmaceutical compositions | |
HUP0203303A3 (en) | Compositions for administering taxanes orally to human patients | |
HUP0301317A3 (en) | Use of neuroprotective 7-beta-hydroxysteroids for preparation of pharmaceutical compositions | |
HUP0303731A3 (en) | Sulfonylguanidines and their use for preparation of pharmaceutical compositions | |
AU2001273919A1 (en) | Pharmaceutical compositions | |
AU2001248772A1 (en) | Sustained release drug compositions | |
AU4489501A (en) | Improvements in and relating to digestive/laxative compositions |